Investor List:

Top Pharmaceuticals Series A Investors in LatAm (Latin America) (29)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Ricardo Salomão, General Partner at Green Rock
Ricardo Salomão
Green Rock·General Partner
Sweet spot: $1.5M
Range: $500K - $3.0M
Investors in Sao Paulo (Brazil)
Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Medical Devices (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Investors who invested in female founders (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Seed), Investors in Wellness & Fitness (Seed), Investors in Wellness & Fitness (Series A), Investors in Medical Devices (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Consumer Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Digital Health (Series A), Investors in Health IT (Pre-seed), Investors in Health IT (Series A), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Pre-seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Seed), Investors in Therapeutics (Series A), Investors in Drug Delivery (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in Medical Devices (Pre-seed), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Pre-seed), Investors in Wellness & Fitness (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in Drug Delivery (Pre-seed), Investors in Wellness & Fitness (Pre-seed), Investors in Drug Delivery (Series A), Investors in Therapeutics (Series A), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Wellness & Fitness (Series A), Investors in Therapeutics (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Drug Delivery (Series B), Investors in Wellness & Fitness (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Wellness & Fitness (Series B), Investors in Therapeutics (Series B), Investors in Health IT (Series B), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Drug Delivery (Series B), Investors in Therapeutics (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B)
Photo of Fernanda Zoppi, Partner at Green Rock
Fernanda Zoppi
Green Rock·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Investors in SMB Software (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in SMB Software (Series A), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in AI (Seed), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in AI (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in Health IT (Seed), Investors in AI (Series A), Investors in SMB Software (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in SMB Software (Series A), Investors in Health IT (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
Photo of Robert Séguin, Managing Partner at Westmount Capital
Robert Séguin
Westmount Capital·Managing Partner
Sweet spot: $150K
Range: $100K - $250K
Investors in Barcelona (Spain), Investors in Madrid (Spain), Investors in Paris (France), Investors in Peru, Investors in Geneva, Investors in Zurich (Switzerland), Investors in Rome (Italy), Investors in Milan (Italy), Investors in Bogota (Colombia), Investors in Medellin (Colombia), Investors in Amsterdam (Netherlands), Investors in Basel (Switzerland)
Photo of Luiz Felipe D Martins Costa, Partner at DNA Capital
Luiz Felipe D Martins Costa
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Photo of Felipe Mora Sarria, Partner at Impulsum Ventures
Felipe Mora Sarria
Sweet spot: $500K
Range: $500K - $500K
Investors in Medellin (Colombia), Investors in Santa Monica (CA), Investors in Barcelona (Spain)
Investors in Medical Devices (Seed), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series B), Investors in Consumer Health (Seed), Investors in FinTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series A), Investors in Los Angeles / Southern California (Other Lists), Investors in Consumer Internet (Seed), Investors in Consumer Health (Seed), Investors in FinTech (Seed), Investors in Health IT (Seed), Investors in Medical Devices (Seed), Investors in Consumer Internet (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Series A), Investors in Consumer Internet (Series A), Investors in FinTech (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Consumer Internet (Series B), Investors in Consumer Health (Series B), Investors in FinTech (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in Consumer Health (Series A), Investors in Pharmaceuticals (Series B), Investors in FinTech (Series B), Investors in Consumer Internet (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Series B), Investors in Consumer Internet (Series B), Investors in Medical Devices (Series A), Investors in Medical Devices (Series B), Investors in Consumer Internet (Series A), Investors in Digital Health (Seed), Investors in FinTech (Seed), Investors in FinTech (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series B), Investors in Consumer Internet (Series A), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in FinTech (Seed)
Photo of Luiz Noronha, Partner at DNA Capital
Luiz Noronha
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Consumer Health (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in FinTech (Series B), Investors in Consumer Health (Seed), Investors in Pharmaceuticals (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in SaaS (Series B), Investors in Health & Hospital Services (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Pharmaceuticals (Series A), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Consumer Health (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in FinTech (Series B), Investors in Health IT (Seed), Investors in SaaS (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Seed), Investors in Consumer Health (Seed), Investors in Consumer Health (Series B), Investors in SaaS (Series B), Investors in SaaS (Series A), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in FinTech (Seed), Investors in FinTech (Series A), Investors in Digital Health (Series B), Investors in SaaS (Series A), Investors in Health IT (Seed), Investors in FinTech (Series A), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in FinTech (Seed), Investors in Health & Hospital Services (Seed), Investors in SaaS (Seed)
Photo of Mitesh Rao, Venture Partner at DNA Capital
Mitesh Rao
DNA Capital·Venture Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Photo of Thayan Hartmann, Partner at DNA Capital
Thayan Hartmann
DNA Capital·Partner
Sweet spot: $2.5M
Range: $100K - $5.0M
Investors in Sao Paulo (Brazil)
Get new data & insights delivered to your inbox